COCA-COLA, BUREAU VERITAS, ACCENTURE TO LEAD FOR 2022 AFRICA EDITION OF CEILING TOUCH THE SKY(R)

Africa’s Best organizations to share and learn best practices for leadership, Diversity & Inclusion, and success on June 1, 2022.

CAPE TOWN, South Africa, March 28, 2022 /PRNewswire/ — House of Rose Professional Pte. Ltd (HORP) today announced that its 2022 Africa Edition of Break the ceiling touch the sky® – the success and leadership summit for women will be held virtually on June 1, 2022, bringing together virtually leaders  from the best Companies in Africa to share best practices on leadership, diversity & inclusion, and success. Coca-Cola, Bureau Veritas, and Accenture will lead as the early sponsors for this Edition.

Logo

Break the ceiling touch the sky® is the world’s leading forum for women in leadership, having inspired and enabled over 30000 women leaders to greater success across editions in Africa, North America, Europe, Middle East, ANZ and Asia since 2015. The summit is based on the best-selling book “Break the ceiling touch the sky: success secrets of the world’s most inspirational women” by Anthony A. Rose, Chairman and CEO, House of Rose Professional.  The summit supports MISSION 2029 FOR A BETTER WORLD – a 10-year global initiative led by HORP and several global partner organizations to shape a better world by quintupling the number of Female CEOs in the worlds 500 largest Companies by 2029 and doubling the number of Male CEOs advocating and investing in diversity & inclusion.  With some of the world’s fastest growing economies in Africa, the Region is expected to contribute significantly towards this Mission.

Commented Philippine Mtikitiki,Vice President, South Africa, The Coca-Cola Company, “Diversity and inclusion is at the core of our business. We continue to invest and make progress in unlocking the full potential of our people with equal access to development and opportunity.  We are delighted to partner with Break the ceiling touch the sky® for this important 2022 Africa Edition and contribute to accelerating the development of human capital in the region.” 

Commented Marc Roussel, President Government Services & International Trade & SVP Africa, Bureau Veritas“An Africa Edition of Break the ceiling touch the sky® is an important development in the mission for global gender diversity & inclusion. Gender diverse companies are financially more successful, better employers, greater innovators, and better corporate citizens. Bureau Veritas Africa looks forward to sharing and learning best practices on leadership, diversity & inclusion best practices alongside many other winning organizations at the 2022 Africa Edition of Break the ceiling touch the sky.”

Vukani Mngxati, Chief Executive Officer & Board Chairman, Accenture in Africa, shared, “We believe the future workforce is an equal one. There is no doubt that the pandemic hit women the hardest. From skyrocketing unemployment to taking on more responsibilities at home, it has never been more important to ensure equitable experiences for women. We expect leaders at all levels to help create and sustain a culture of equality. I personally believe that inclusion helps us to unleash greater innovation and enables  our people to perform at their very best. Through Break the ceiling touch the sky® we share our learnings on leadership, diversity & inclusion to benefit the broader industry and  learn from others’ best practices as well.”

Companies or individuals can register for the summit at

https://houseofroseprofessional.com/btctts-world-tour-2022/africa-2022/

House of Rose Professional Pte. Ltd® is a global leader in the Talent, Training and Transformation businesses via its three core brands Break the ceiling touch the sky® (Training), Dream Job International®(Talent) and CEOSmith® (Transformation).

Inquiries contact:

Anthony A. Rose
House of Rose Professional Pte. Ltd.
Email: anthony@houseofroseprofessional.com
www.houseofroseprofessional.com

Logo – https://mma.prnewswire.com/media/1559937/House_of_Rose_Professional_Logo.jpg

Vela Diagnostics présente ses panels de séquençage des gènes du cancer ciblés (60 gènes) et complets (525 gènes) basés sur les NGS

HAMBOURG, Allemagne, 28 mars 2022  /PRNewswire/ — Vela Diagnostics a annoncé aujourd’hui le lancement de ses nouveaux panels de séquençage OncoKey® SL 60 et 525 Plus. Ces panels basés sur les systèmes de séquençage de nouvelle génération (NGS) sont conçus pour détecter les biomarqueurs d’ADN et d’ARN du cancer à partir d’échantillons de tissus fixés au formol et inclus en paraffine (FFPE), pour un maximum de 64 échantillons par cycle de séquençage.

Vela Diagnostics propose deux panels de séquençage des gènes du cancer : le système OncoKey® SL 60 Plus et le système complet OncoKey® SL 525 Plus. Avec seulement 40 ng d’acide nucléique, le panel de séquençage peut détecter les biomarqueurs suivants en un seul test : polymorphisme d’un seul nucléotide (PSN), insertions ou délétions (indel), variations du nombre de copies (copy number variations, CNV), instabilité des microsatellites (microsatellite instability, MSI), fusions, épissage alternatif, virus et bactéries oncogènes, et peut mesurer la charge mutationnelle tumorale (CMT).

Ces panels basés sur les NGS présentent un flux de travail hautement automatisé, de l’échantillon au résultat. Ils peuvent produire des résultats en cinq jours, ne nécessitent que 2,5 heures de travail manuel et assurent une traçabilité élevée des échantillons, de l’extraction automatisée des échantillons au contrôle de la qualité (CQ) des données. VELA® Analytics permet de créer des rapports internes concis, fondés sur des données probantes, qui fournissent aux clients les informations nécessaires pour prendre des décisions éclairées quant aux options de traitement possibles. Par ailleurs, les laboratoires disposant de peu d’échantillons peuvent choisir d’effectuer les tests manuellement.

Le flux de travail des panels OncoKey® SL 60 et 525 Plus repose sur les plateformes de séquençage Illumina. Les panels peuvent donc s’adapter sans problème aux situations actuelles des laboratoires. Associés à des adaptateurs UMI-UDI doubles, à un système de capture par hybridation, à un séquençage par synthèse et à un pipeline bio-informatique validé avec soin, les panels présentent une sensibilité élevée et un profilage complet des variantes, ainsi qu’une couverture de séquençage uniforme.

« Les panels OncoKey® 60 et 525 Plus de VELA sont un formidable progrès dans la médecine de précision pour le cancer, a déclaré le Dr Andreas Goertz, directeur général de la division européenne de Vela Diagnostics. Ces panels sont composés de gènes pertinents d’un point de vue clinique et ont été conçus sur la base de contributions de personnalités influentes dans le domaine de l’oncologie, ainsi que de références à des directives professionnelles, à des essais cliniques et à des bases de données sur le cancer. »

« Vela Diagnostics prévoit de rendre disponibles les panels OncoKey® 60 et 525 Plus au quatrième trimestre 2022 aux États-Unis et en Asie-Pacifique, a ajouté Sam Dajani, PDG et président exécutif de Vela Diagnostics. L’utilisation de ces panels sur le flux de travail automatisé de Vela Diagnostics permettra de réduire les erreurs humaines et de minimiser la contamination croisée des échantillons qui peut être engendrée par un flux de travail manuel. Par ailleurs, nos solutions et services VELA® Analytics peuvent identifier et interpréter les variantes génétiques dans les tumeurs, ce qui permet de fournir rapidement et avec précision des options exploitables aux professionnels de la santé et de la recherche. »

À propos de Vela Diagnostics

Vela Diagnostics est un fournisseur de premier plan de solutions intégrées de diagnostic in vitro, de l’échantillon au résultat. Les solutions de test de VELA utilisent la plateforme automatisée Sentosa®, et offrent la possibilité unique d’utiliser un seul système pour les tests NGS et PCR dans le domaine des maladies infectieuses et de l’oncologie.

Tous les produits Sentosa® énumérés ci-dessus sont de Vela Diagnostics. Pour plus d’informations, consultez le site www.veladx.com. Tous les autres noms de produits, marques déposées et logos sont la propriété de leurs détenteurs respectifs.

Contact pour les médias :

vince.yip@veladx.com

 

 

Vela Diagnostics Launches Focused (60 Genes) and Comprehensive (525 Genes) NGS-Based Pan-Cancer Panels

HAMBURG, Germany, March 28, 2022 /PRNewswire/ — Vela Diagnostics announced today the launch of its new OncoKey® SL 60 and 525 Plus Panels. These next-generation sequencing (NGS)-based panels are intended for detection of DNA and RNA cancer biomarkers from formalin-fixed paraffin-embedded (FFPE) tissue specimens, for up to 64 samples in a single sequencing run.

Vela Diagnostics offers two pan-cancer gene panels: the focused OncoKey® SL 60 Plus Panel, and the comprehensive OncoKey® SL 525 Plus Panel. With just 40 ng of nucleic acid, the panel can detect the following biomarkers in one assay: single nucleotide variations (SNVs), insertions/deletions (INDELs), copy number variations (CNVs), microsatellite instability (MSI), fusions, splice variants, oncogenic viruses and bacteria, as well as measuring the tumor mutation burden (TMB).

These NGS-based panels feature a highly-automated, sample-to-result workflow. They are able to produce results within 5 days, requiring only 2.5 hours of hands-on time, and provide high sample traceability, from automated sample extraction to data quality control (QC). VELA® Analytics can create concise, evidence-based in-house reports that help customers with the information to make timely, informed decisions about possible treatment options. Additionally, laboratories with low sample volumes can choose to perform the assays in a manual workflow.

Crucially, the OncoKey® SL 60 and 525 Plus Panel workflow is wrapped around Illumina sequencing platforms. Thus, the panels can be seamlessly adapted to current lab situations. Combined with dual UMI-UDI adapters, hybrid capture target enrichment, sequencing by synthesis and thoroughly validated bioinformatics pipeline, the panels boast high sensitivity and comprehensive variant profiling, plus sequencing coverage uniformity.

“VELA’s OncoKey® 60 and 525 Plus Panels represent an exciting development in precision medicine for cancer,” said Dr Andreas Goertz, Managing Director of Vela Diagnostics’ European organization. “These panels consist of clinically relevant genes of interest and were designed based on input from key opinion leaders in oncology, as well as references to professional guidelines, curated clinical trial and cancer databases.”

“Vela Diagnostics is planning to launch our OncoKey® 60 and 525 Plus Panels in Q4 2022 in the USA and Asia Pacific,” said Sam Dajani, CEO and Executive Chairman of Vela Diagnostics. “Using these panels on Vela Diagnostics’ automated workflow will reduce human error and minimize sample cross contamination which can be generated by using a manual workflow. In addition, our VELA® Analytics solutions and services can identify and interpret genetic variants in tumors making it possible to provide actionable options for healthcare and research professionals quickly and accurately,” added Mr Dajani.

About Vela Diagnostics

Vela Diagnostics is a leading provider for integrated IVD system solutions, from sample to result. VELA’s test solutions utilize the automated Sentosa® platform, providing the unique ability to leverage one system for NGS and PCR testing in infectious disease and oncology.

All Sentosa® products listed above are by Vela Diagnostics. For more information, visit www.veladx.com. All other product names, trademarks and logos are the property of their respective owners.

Media Contact

vince.yip@veladx.com

Presales Open for Metahunter: The Metaverse for All

The combination of MMORPG, Sandbox, and open-world concepts opens the door to a new Metaverse.

SINGAPORE, March 28, 2022 /PRNewswire/ — A new dawn is coming to the virtual world in the shape of Metahunter, a platform that is focused on accessibility, education, and opportunity for any and all who want to experience the metaverse. Presales have now begun at https://metahunter.com/.

Metahunter Logo

With over 500 influencers onboarded into the ecosystem, Metahunter is on track to becoming the largest Metaverse space in the world. Metahunter aims to become the Metaverse for all by providing equal opportunity to all regardless of social level, becoming the first of many to make the virtual experience a reality for millions of unserved people worldwide.

Metahunter Influencers Community

Unlike many other projects created in the market, Metahunter isn’t just trying to take advantage of the hype and short-term profits. Instead, Metahunter makes the Metaverse experience accessible to tens of millions of people in the market who don’t currently have the opportunity and knowledge to participate due to high entry costs and other barriers.

Not only does Metahunter provide a beginner-friendly platform, but it also provides a place for newcomers to learn more about play-to-earn gaming and blockchain technology. It gives everyone a chance to get into Metaverse at an affordable price. The new platform will offer those that haven’t been able to participate in play-to-earn gaming a unique first-time opportunity.

Allen Tan Chee Hoe

Founded by Allen Tan Chee Hoe, who previously founded Findwork, a recruitment platform with over 4 million verified and certified users that connects underserved personnel to working opportunities. Currently, Allen leads the Metahunter team of seasoned executives in blockchain, technology, capital markets, marketing, entrepreneurship, gaming, influencers, community builders, and more. The Metahunter team has a background from companies like Facebook Gaming, SuperCell, J.P. Morgan, Renaissance Capital, etc.

Unlike other platforms which rely on bots or other sources to generate traffic, Metahunter will build an organic approach. With a possible outreach of at least 100 million people globally, Metahunter is on track to create the most immersive Metaverse experience.

Metahunter is a “Metaverse for All” where everyone can play, learn, and earn together. Take advantage of this early opportunity, and let’s build the largest Metaverse world together!

Logo – https://mma.prnewswire.com/media/1766819/logo_final_Logo.jpg
Photo – https://mma.prnewswire.com/media/1769461/1.jpg
Photo – https://mma.prnewswire.com/media/1769462/2.jpg

COVID-19 pandemic- health workers affirm improvements in infection prevention and control

Abuja, 28 March, 2022 – “It’s hard to remember life without COVID-19 anymore, we have become so used to wearing masks and preventives that not doing so makes it look weird” says Dr Oje Uzochi, a Medical Officer at Asokoro General Hospital, Federal Capital Territory (FCT) Abuja.

The 35-year-old pediatrician also mentioned that despite the sad incidents COVID-19 left behind, it has also helped in improving infection prevention and control (IPC) in hospitals.

To Dr Uzochi, “We are much more protected now, it is good to say we do not take as much diseases home as we used to and I have had less flu in the last few years than before the pandemic. Most times children can cough on your face during consultation and you tend to get infected after a few days, it is not like that anymore”.

“Patients are generally much more aware of hygiene as I could remember struggling with parents to wash hands, sterilize things and be conscious of their environment, but now they do it themselves so there are less diseases presented at the hospital presently.”

Another health practitioner, 47-year-old intensive care unit (ICU) nurse at the same hospital, Mr Apollos Haruna, who has been practicing for over 20 years, also shared his experience. To him, “COVID-19 has changed and improved the entire hospital system in terms of infection prevention and control. Before the pandemic, we weren’t taking things like handwashing seriously, but now it has become the norm, we do instinctively, whether we interact with people or not.”

Also, he said, “I used to face some kind of stigma especially because the hospital I worked for was a COVID-19 treatment center, people were always distancing themselves from me thinking I would transfer the virus to them, luckily for me as I was very strict with the COVID-19 guidelines I never contracted the virus”.

It has been two years into the COVID-19 pandemic, results of a study conducted nationwide by the Nigeria Centre for Disease Control (NCDC), shows that over 50 per cent of Nigerians have been exposed to the virus, and have antibodies for COVID-19.

The first case of the virus was detected in Nigeria on February 27, 2020. According to the Nigeria Centre Disease Control (NCFC), the country has since then confirmed over 250 000 cases, with over 3 000 deaths.

While commemorating the two years’ anniversary of COVID-19 in Nigeria, the Director General NCDC Dr Ifedayo Adetifa mentioned that several efforts have been made towards improving the health system, as well as increased investment in response to the COVID-19 pandemic in the past few years. During the pandemic, the NCDC supported the establishment of infectious disease treatment centers, molecular laboratories, and public health emergency operation centers in all States, and provided equipment required for critical care in hospitals.

“NCDC has also led the training of over 40 000 health workers on infection prevention and control, completed the digitalization of the country’s infectious disease surveillance system, provided support including vehicles for outbreak investigation across states, and ensured regular supplies of treatment and testing supplies among other activities”.

He further called on Nigerians who are yet to take the vaccine to hastily do so to ensure a COVID-19 free Nigeria.

In a bid to keep lowering infection rates, Nigeria’s Federal Capital Territory and all 36 state governments have invested in training their health workers with the support of WHO. The national and state governments have also strived to make personal protective equipment and other essential supplies more readily available to health workers. Nigeria has benefited from the United Nations Solidarity Flight campaign, which distributed essential medical supplies including personal protective equipment and ventilators.

“The training of the first set of trainers for IPC across the six geopolitical zones of the country was supported by WHO. Thereafter WHO supported specific state level trainings on IPC. WHO also supported the development of the first national IPC manual for the country and is currently supporting the review of the National IPC policy” says Professor Adebola Olayinka, WHO Nigeria focal person on IPC.

WHO will continue to support Nigeria on IPC and making sure the pandemic is contained.

Source: World Health Organization. Africa

Nigeria bolsters laboratory capacity for antimicrobial resistance towards Universal Health Coverage

Abuja, 28 March, 2022 – Imagine a world where medical treatment of routine ailments or operations become life-threatening and stop responding to drugs. The seemly far-fetched scenario is becoming real and a danger to medical interventions with the emergence of antimicrobial resistance (AMR).

In the case of Yomi Ade (not real name), a 21- years old who lives in Ile -Ife, Osun State, had to spend 87 days in the hospital after being diagnosed with blood sepsis because his aliment was not responding to any of the medication administered.

Being a sickle-cell patient, Mr Ade had hip surgery some months earlier but – recovered and went back to school. He later fell ill and was rushed home and taken to the Obafemi Awolowo University Teaching Hospital, Ile-Ife, Osun State, in South-West Nigeria, where he spent almost three months.

“I missed a semester and could not graduate with my classmates because I was in the hospital. My case was complex as it was not responding to almost all the antibiotics administered. The doctors were perplexed, and this affected me psychologically. It was so bad as there seemed to be no cure for the ailment”, he said.

“Yomi is not the only peculiar case of antibiotic resistance we have recorded in this hospital. We have had patients whos were also not responding to the first and second lines of antibiotics treatment options. The emerging threats have forced health care professionals to use reserved and more expensive antibiotics to combat the diseases”,Professor Oladipo Aboderin, a Consultant Clinical Microbiologist at the Obafemi Awolowo University Teaching Hospitals, Ile-Ife, Nigeria said.

Professor Aboderin said it has become essential for countries to address AMR for universal health coverage (UHC) strategy to be truly successful.

He said, “We thought AMR was a faceless threat to medical procedures and treatments. However, with recent happenings, there is a need for intentional and extensive research to understand the magnitude of the problem within society.

AMR in patients has unmeasurable consequences on the patients and their families, to mention a few it has emotional, financial, psychological and time-consuming effects. There is always huge out of pocket spending because the higher the generic prescribed, the more expensive and difficult it is to purchase. It defeats the goal of achieving universal health coverage”, he said.

Strengthening health system capacities

To achieve UHC globally, the World Health Organization (WHO) agrees that it is critical to address AMR by effectively strengthening the health care systems.

To this end, WHO has been supporting Nigeria to improve surveillance ( in 10 sentinel sites) and AMR stewardship (3 selected tertiary hospitals) in response to the WHO Global Action Plan on AMR.

Mr Omotayo Hamzat, WHO technical officer, said WHO is leading the Antimicrobial Stewardship in Nigeria and has supported NCDC to develop and implement the current National Action Plan.

According to him, bacteria spread freely in the environment, “But we are promoting a multi-disciplinary response to tackle AMR that includes human health, animal health, food production and the environment.

A Point Prevalence survey was conducted in the six geopolitical zones (one state in each zone), with the data analyzed and interpreted through technical assistance from WHO.

The results are being used to support three selected hospitals namely; Obafemi Awolowo University Teaching Hospital Ile-Ife Osun State, National Hospital Abuja and the Niger Delta University Teaching hospital Yenogoa, Bayelsa State, to institutionalize the Antimicrobial Stewardship programme in the hospitals.

Mr Hamzat said WHO supports the national One Health AMR surveillance systems by investing in human and animal health laboratories and promoting data sharing, analysis and joint action between human, animal, and environmental government ministries.

Meanwhile, Professor Aboderin said “The surveillance and stewardship support by WHO would support easy diagnosis and ensure responsible drug use in the country to mitigate the heaviest consequences of the spread of AMR.”

Globally, AMR is a threat to health and development. It requires urgent multisectoral action to achieve the Sustainable Development Goals. AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines making infections harder to treat and increasing the risk of disease spread, severe illness and death. As a result of drug resistance, antibiotics and other antimicrobial medicines become ineffective, and infections become increasingly difficult or impossible to treat.

Source: World Health Organization. Africa

Kenyan lab boosting Africa’s genome surveillance

Kilifi, Kenya – Amid the soft purr of the air conditioner and glinting LED screens, laboratory technicians inside a sprawling facility on the Kenyan coast peer into test tubes and pore through spreadsheets, hard at work to help propel Africa’s efforts to monitor and detect COVID-19 variants and boost pandemic response.

Genome sequencing at the laboratory in the Kenya Medical Research Institute in the coastal Kilifi town previously focused on research projects, sequencing about two dozen samples a week.

Then the pandemic struck.

Now serving five countries and part of the continent-wide 12 laboratory network set up to upscale the region’s pathogen surveillance through genome sequencing, the Kilifi laboratory sequences up to 200 samples weekly, although it has a capacity of up to 700.

Genome sequencing is central to combatting COVID-19, allowing governments and health authorities to take swift and informed public health decisions such as measures to bolster preparedness for potential surges owing to more infectious variants or stepping up vaccination, diagnostics and treatment.

“A genome sequence is like a fingerprint for the virus,” says Dr George Githinji, Team Lead of Genomic Surveillance at the Kenya Medical Research Institute in Kilifi. “From a sequence we learn about the history of the virus, which helps us understand transmission patterns and how to keep [COVID-19] from spreading.”

The laboratory has produced more than 8000 sequences since April 2020 from samples sent by Comoros, Eswatini, Ethiopia, Seychelles, Sudan as well as from within Kenya. A quarter of those samples were shipped in from the five countries within the sub-region.

World Health Organization (WHO) recommends that countries ship at least 5% of their COVID-19 samples to reference sequencing laboratory or continuously produce sequencing data if they have the capacity.

“The more sequences the better,” says Dr Nicksy Gumede-Moeletsi, Regional Virologist at WHO Regional Office for Africa. “Because the virus is always changing, it’s important that samples from all over the continent are sequenced regularly so we can understand SARS-CoV-2 as it evolves.”

It takes three days to go from sample to sequence at the Kilifi laboratory, but around two weeks to fully process samples sent from other countries and provide complete analysis. Sequencing is a detailed process and can also be costly, especially when samples are sent from abroad. Shipping alone can cost up to US$ 500 for each delivery. There are also a multitude of approvals needed before the deliveries can move forward.

“WHO acts as a broker, facilitating agreements, navigating customs, managing paperwork and organizing logistics,” says Dr Juliet Nabyonga, acting WHO Representative in Kenya. “Our teams work with governments and labs to speed up the administrative processes so that samples can arrive cold and intact.”

Dr Gumede-Moeletsi points out that sending samples from one country to another for sequencing is a “stop-gap solution,” adding that “ultimately, countries have to be able to sequence and analyse genomes without relying on outside support.”

African countries are making great strides towards self-sufficiency in genome sequencing. After receiving WHO training, Eswatini now sequences its own COVID-19 samples and no longer sends samples to Kenya. Comoros is about to follow suit after its laboratory technicians received training from WHO, which is also helping the country procure its own sequencing machine. With WHO support, the Kilifi laboratory is set to train laboratory technicians from Ethiopia and Tanzania.

Countries including Chad, Mauritius, Namibia and Zimbabwe which previously sent samples to regional reference laboratories outside their territories now have their own sequencing laboratories.

WHO has provided more than US$ 6.5 million to help African countries either increase existing sequencing capabilities or build new expertise. It has paid off. At the beginning of 2021, just 5000 sequences had been produced continent-wide. Now, African laboratories have generated genetic profiles of more than 93 000 samples of SARS-CoV-2.

“We have built capacity on analysis on bioinformatics. We can draw a lot of synergy and strength by focusing on pathogens of interest by building collaborations and supporting analysis,” says Dr Githinji. “It’s not just enough to know what’s circulating. You need the analysis to make the sequencing meaningful so it has an impact on policy.”

Genome sequencing can revolutionize public health and transform responses to other major health threats beyond COVID-19. Over the past two decades, genome sequencing has been pivotal in the efforts to tackle HIV, tuberculosis, Ebola, polio, measles, hepatitis B and C among others in Africa.

Source: World Health Organization. Africa

Air Force helicopter at service of electoral brigades

Malanje – A National Air Force helicopter was made available in recent days to fly logistics and firefighters in remote areas of the northern Malanje province to allow the update of the Ex-officio electoral registration.

The regions are those of the municipalities of Marimba, Massango, Quela, Quirima and Cunda-Dia-Base, according to the director of the Provincial Office for Registries and Administrative Modernisation, Lando David Pacheco.

The official explained only 65 percent of the voting-age population has registered so far, when a few days are left before the end of the process.

He called for the need to mobilise air resources to help reach the remote areas.

The Ex-officio electoral registration started in September 2021 and runs until March 31 this year, with forecasts to cover 228, 059 voters in Malanje province’s 14 municipalities.

At this time the number of updates stands at 150,000.

Source: Angola Press News Agency

Amnesty International Report 2021/22: The state of the world’s human rights

Sub-Saharan Africa: Millions denied vaccines, deepening inequality and human suffering from conflicts sum up 2021

– Amnesty International releases its Annual Report for 2021

– Global leaders peddling false promises of a fair recovery from Covid-19 to address deep-seated inequalities, with only 8% of Africa’s 1.2 billion people fully vaccinated by end of 2021 – Utter failure of the global community and African Union leaders as civilians continued to pay the price of protracted armed conflicts in Africa

– The impact has been exacted on the most marginalized communities in the world including those in Africa, Asia and Latin America, says Amnesty International

Wealthy states colluded with corporate giants in 2021 to dupe people with empty slogans and false promises of a fair recovery from the Covid-19 pandemic while many people from Africa were denied life-saving vaccines, in what amounts to one of the greatest betrayals of our times, said Amnesty International today, as it launched its annual assessment of human rights around the world.

Amnesty International Report 2021/22:The State of the World’s Human Rights finds that these states, alongside corporate titans, have in fact driven deeper global inequality, with most African countries left struggling to recover from Covid-19 due to high levels of inequality, poverty and unemployment exacerbated by unequal distribution of vaccines.

“Covid-19 should have been a decisive wake-up call to deal with inequality and poverty. Instead, we have seen deeper inequality and greater instability in Africa exacerbated by global powers, especially rich countries, who failed to ensure that big pharma distributed vaccines equally between states to ensure the same level of recovery from the Covid-19 pandemic,” said Deprose Muchena, Amnesty International’s Director for East and Southern Africa.

“As things stand now, most African countries will take long to recover from Covid-19 due to high levels of inequality and poverty. The after-effects of Covid-19 have been most damaging to the most marginalized communities, including those on the front lines of endemic poverty from Angola to Zambia, Ethiopia to Somalia and the Central Africa Republic to Sierra Leone.”

Corporate greed and self-interested nationalism undercuts vaccination in Africa

Multiple waves of the pandemic tore through Africa, having a devastating impact on human rights. Governments’ efforts, in countries such as Somalia, South Africa, Zambia, Senegal and Sierra Leone, to stem its tide were hindered by the global vaccine inequality created by pharmaceutical companies and wealthy nations. By the year’s end, less than 8% of the continent’s 1.2 billion people had been fully vaccinated.

Nearly 9 million cases and more than 220,000 deaths were recorded during the year. South Africa remained the epicenter of the pandemic, in terms of reported cases and deaths.

Meanwhile, wealthy states such as EU member states, the UK and the USA stockpiled more doses than needed, whilst turning a blind eye as Big Pharma put profits ahead of people, refusing to share their technology to enable wider distribution of vaccines. In 2021, Pfizer, BioNTech and Moderna projected eye-watering profits of up to US$54 billion yet supplied less than 2% of their vaccines to low-income countries. Vaccination distribution continues to be painfully slow across the continent, igniting fears of deepening poverty and a prolonged economic recovery.

“Rich and powerful countries used money and their political influence to procure hundreds of millions of doses, shutting poor countries out of the market,” said Samira Daoud, Amnesty International West and Central Africa Director.

“The result was inequitable distribution of these much-needed vaccines, meaning that most people in low-income countries would become the last to be inoculated, as if one’s financial status or nationality was the qualifying criteria to get vaccinated.”

Pandemic lays bare poor healthcare infrastructure, and inequality, while gender-based violence continued to increase across Africa

The devastating consequences of collusion between corporate giants and western governments was compounded by health systems and economic and social support crumbling under the weight of decades of neglect. The result was rising poverty, inequality and food insecurity. Nowhere was this felt more clearly and cruelly than in Africa, which is why Amnesty International launches its report today from South Africa.

With less than 8% of the continent’s population fully vaccinated by the end of 2021, it holds the lowest vaccination rate in the world, beleaguered by insufficient supplies provided to the COVAX facility, the Africa Vaccine Acquisition Trust and through bilateral donations.

Too often, supplies were insufficient, or their arrival times unpredictable, making it hard for governments to build trust among their populations and structure effective roll out campaigns. In countries like DRC, Malawi and South Sudan vaccine deliveries arrived with short expiry dates forcing authorities to destroy supplies or return the bulk for reallocation to other countries.

The Covid-19 pandemic also highlighted the region’s chronic lack of investment in health sectors over many decades. The already inadequate healthcare systems in most countries were severely strained, especially during the pandemic’s third wave. In Somalia, only one hospital in Mogadishu, the capital, handled all Covid-19-related cases across south central regions for much of the year. Allegations of corruption, including in relation to Covid-19 funds, further undermined health sectors in many countries, including Cameroon and South Africa.

The pandemic has also resulted in many people across Africa left behind in terms of education, including Uganda, which will result in cementing inequality going forward. In South Africa, approximately 750,000 children had dropped out of school by May, over three times the pre-pandemic number.

Gender discrimination and inequality remained entrenched in African countries. Major concerns documented in the region included spikes in gender-based violence, limited access to sexual and reproductive health services and information, the persistence of early and forced marriage, and the exclusion of pregnant girls from schools.

Conflict continues across Africa amidst weak regional and international response

The global failure to build a global response to the pandemic mirrored the global and African Union’s failure to address human rights violations in conflicts on the African continent.

Human rights abuses in the conflicts on the continent continued unabated in 2021 partly because of the inaction of the African Union Peace and Security Council. Its failure to act on atrocities was most evident in relation to the conflicts in Ethiopia and Mozambique. Despite harrowing accounts of human rights violations that continuously emerged from the conflicts in the two countries, the Peace and Security Council remained disturbingly silent.

New and unresolved conflicts erupted or persisted in Mali, Burkina Faso, Niger, Central African Republic, Nigeria, Cameroon, Ethiopia, South Sudan and Mozambique, with warring parties violating international human rights and humanitarian law. In their wake, civilians were made collateral damage, millions were displaced, thousands killed, hundreds subjected to sexual violence, and already fragile healthcare and economic systems were brought to the brink.

In the conflict in northern Ethiopia, the Ethiopian government forces alongside the Eritrean Defense Forces (EDF), and the Amhara police and militia continued to fight against the Tigrayan forces in a conflict that started in November 2020, affecting millions. During the conflict, members of the EDF, as well as Ethiopian security forces and militia, committed serious human rights violations, including sexual violence against women, unlawful killings, and forced displacement. Tigrayan forces also were responsible for serious violations, including unlawful killings, rape and other sexual violence constituting crimes against humanity and war crimes.

Humanitarian aid was denied to millions of people in Tigray, resulting in many facing life-threatening conditions. Detainees in West Tigray were subjected to torture, extrajudicial execution, starvation, and denial of medical care.

In Mozambique, civilians continued to be caught between three armed forces in the conflict in Cabo Delgado, in which more than 3,000 people have died since the conflict began in October 2017. Nearly 1 million people (primarily women, children and older people) were internally displaced as a result of the war.

In Central African Republic, unlawful attacks, including killings and other violations and abuses of international humanitarian and human rights law, some of which amount to war crimes, were committed by all parties to the conflict. According to the UN, members of the Coalition of Patriots for Change (CPC) attacked and looted health centres in Mbomou prefecture in January.

In Mali, Niger and Burkina Faso, hundreds of civilians were killed by various armed groups.

Governments hiding behind security and Covid-19 to stifle dissent

Global trends to stifle independent and critical voices gathered steam in 2021 across Sub-Saharan Africa as governments deployed a widening gamut of tools and tactics.

Measures to curb the spread of Covid-19 provided additional pretext for the repression of peaceful dissent across the region, with the first instinct of many governments to ban peaceful protests, citing health and safety concerns, including in Cameroon, Chad, Côte d’Ivoire, Lesotho and Zimbabwe.

Meanwhile, in countries like Eswatini and South Sudan, organizers were arrested, and the

internet disrupted to derail planned protests. Security forces used excessive force to break up peaceful protests of hundreds or thousands of people who defied bans. In over 12 countries, including Angola, Benin, Senegal, Chad, Eswatini, Guinea, Nigeria, Sierra Leone and Sudan, many people died when security forces fired live ammunition. In Eswatini, the violent dispersal of pro-democracy protests resulted in 80 deaths and more than 200 injuries over five months. In Sudan, at least 53 people died when security forces used live ammunition to disperse protests against the October military coup.

In Chad, at least 700 people protesting against the electoral process and later against the establishment of the transitional government were arrested. In DRC, three activists arrested in North Kivu for organizing a peaceful sit-in to protest mismanagement in a local healthcare administration remained in detention. In Eswatini, at least 1,000 pro-democracy protesters, including 38 children, were arbitrarily arrested.

“Instead of providing room for discussion and debate so sorely needed on how best to meet the challenges of 2021, many states redoubled efforts to muzzle critical voices.”

Human rights wins against all odds

Nevertheless, 2021 was not all doom and gloom. Some key human rights wins were recorded across Sub-Saharan Africa after persistent campaigning for freedoms.

Following months of relentless pro-democracy protests by the people of Eswatini, King Mswati conceded to calls for dialogue to negotiate the future of the country with pro-democracy protesters. This offers new hope for a country where political reforms were not up for negotiations with the monarch.

In Sudan, we saw people’s power in full display when civilians took to the streets in October to reject a military takeover of power by soldiers and reversals of human rights gains during the transitional period.

In Cote d’Ivoire and Guinea, dozens of members or sympathizers of opposition parties as well as members of civil society organizations who were arbitrary arrested for having simply exercised their freedoms of expression or peaceful assembly were released.

Reclaiming our freedoms

In 2022, if governments are intent on building back broken – then we are left with little option. We must fight their every attempt to muzzle our voices and we must stand up to their every betrayal. It is why, in the coming weeks, we are launching a global campaign of solidarity with people’s movements, a campaign demanding respect for the right to protest. We must build and harness global solidarity, even if our leaders won’t.

Source: Amnesty International

Young Angolans in Brazil join voter registration

Luanda – Around 30 young Angolans, residents of the cities of Goiás and Anápolis, went Sunday to the consular sector of the Angolan Embassy in Brazil, in Brasilia, where they provided data for renewal of their Identity Card and Electoral Registration.

According to a note from the Communication and Press sector of the Angolan diplomatic representation in Brazil, after completing the formalities of the process, the group, most of them students, expressed their happiness and satisfaction for the duty of citizenship fulfilled.

For Flávio Domingos, student of physiotherapy at the Unievangelica in Anápolis, it was a historic moment because he managed to register and, for the first time, will vote even living abroad.

Margarida Brás, a Master’s student in the speciality of Nursing at Work, did not hide her enormous satisfaction at the fact that she is now able to vote because, as she stressed, the welfare and development of the Angolan nation involves the holding of elections, the main barometer of democracy.

The process of voter registration, which began on 17 January and is due to close on 31 March, is being carried out in the Angolan capital.

31 March, is taking place in the Brazilian Diaspora, in the Consular Sector of the Angolan Embassy in Brasilia and in the Consulates General in São Paulo and Rio de Janeiro.

Source: Angola Press News Agency